1 / 31

Intracranial Hypertension

Intracranial Hypertension. Pediatric Critical Care Medicine Emory University Children’s Healthcare of Atlanta. Historical Perspective. Alexander Monro 1783 described cranial vault as non-expandable and brain as non compressible so inflow and out flow blood must be equal

webster
Télécharger la présentation

Intracranial Hypertension

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Intracranial Hypertension Pediatric Critical Care Medicine Emory University Children’s Healthcare of Atlanta

  2. Historical Perspective • Alexander Monro 1783 described cranial vault as non-expandable and brain as non compressible so inflow and out flow blood must be equal • Kelli blood volume remains constant • Cushing incorporated the CSF into equation 1926 • Eventually what we now know as Monro-Kelli doctrine • Intact skull = sum of brain, blood & CSF is constant

  3. Monroe-Kellie Doctrine • Skull is a rigid structure (except in children with fontanels) • 3 components: • Brain: 80% of total volume, tissues and interstitial fluid • Blood: 10% of total volume = venous and arterial • CSF: 10% of total volume • Vintracranial = Vbrain + VCSF + Vblood • An increase in one component occurs in the compression of another

  4. Monroe-Kellie Doctrine Copied from Rogers Textbook of Pediatric Intensive Care

  5. Brain • 80% of intracranial space = 80% water • Cell types • Neurons: Cell body, dendrites, axon, pre-synaptic terminal-neurotransmission • Astrocytes/Pericytes • Support the neurons & other glial cells by isolating blood vessels, sypnapses, cell bodies from external environment • Endothelial cells • Joined a tight junctions  form BBB • Oligodendrocytes • Myelin sheath around axons  propagates action potential  efficient transmission of information • Microglia • Phagocytes, antigen-presenting cells, secrete cytokines

  6. CSF • 10% of total volume • Choroid plexus > 70 % production • Transependymal movement fluid from brain to ventricles ~30% • Average volume CSF in child is 90cc (150cc in adult) • Rate of production: 500cc/d • Increase ICP • Decrease production • Increase absorption (up to 3X via arachnoid villa)

  7. Blood • 10% of intracranial volume • Delivered to the brain via the Circle of Willis  course through subarachnoid space before entering brain • Veins & sinuses drain into jugular veins • Cerebral blood volume (CBV) • Contributes to ICP • Cerebral blood flow (CBF) • Delivers nutrients to the brain

  8. CBF & CPP • Morbidity related to ICP is effect on CBF • CPP = MAP- ICP or CPP= MAP- CVP • Optimal CPP extrapolated from adults • In intact brain there is auto-regulation • Cerebral vessels dilate in response to low systemic blood pressure and constrict in response to higher pressures

  9. CBF CBF 50 150 MAP

  10. Auto-regulation of CBF • Compensated via vascular tone in the cerebral circulation to maintain a relatively constant CBF over changes in cerebral perfusion pressure (CPP) • Brain injury causing ICP may abolish auto-regulation • CPP becomes linearly dependent on MAP

  11. CBF 125 PaCO2 CBF PaO2 0 125 CPP

  12. Auto-regulation in Newborns Narrow CPP range vs. adults, similar lower limit, upper limit ~90-100; Rogers Textbook of Pediatric Intensive Care

  13. CPP • 2003 Pediatric TBI guidelines recommend • Maintain CPP>40mmHg • Will likely be modified to titrate to age-specific thresholds • 40-50mmHg: infants & toddlers • 50-60mmHg: children • >60mmHg: adolescents

  14. Wave forms

  15. CBF • CBF is usually tightly coupled to cerebral metabolism or CMRO2 • Normal CMRO2 is 3.2 ml/100g/min • Regulation of blood flow to needs mostly thought to be regulated by chemicals released from neurons. Adenosine seems to be most likely culprit

  16. Cerebral Edema • Vasogenic • Increased capillary permeability disruption BBB • Tumors/abscesses/hemorrhage/trauma/ infection • Neurons are not primarily injured • Cytotoxic • Swelling of the neurons & failure ATPase Na+ channels • Interstitial • Flow of transependymal fluid is impaired (increased CSF hydrostatic pressure

  17. ICP Monitoring • Intraventricular catheter • Intraparenchymal monitor • Subdural device • Epidural catheter

  18. Intraventricular Catheter - Most direct, more accurate, “gold standard” • Can re-zero • Withdraw CSF • Risk: infection, injury, bleeding, hard to place in small ventricles • Infection rate about 7% (level our after 5 days)

  19. Intraparenchymal Catheter • Placed directly into brain, easy insertion • Can’t recalibrate; monitor drifts over time • Lower risk of complication • Minimal differences between intra-ventricular & parenchymal pressures • ventricular ~2 mmHg higher

  20. Monitoring • CT • Helpful if present • Good for skull and soft tissue • MRI w/ perfusion • Assess CBF • Can detect global and regional blood flow difference • PET • Gold standard detect CBF

  21. Management Strategies • CSF • Brain • Blood

  22. Treatment: CSF • Removing CSF is physiologic way to control ICP • May also have additional drainage through lumbar drain • Considered as 3rd tier option • Basilar cisterns must be open otherwise will get tonsillar herniation • Decreasing CSF production: Acetazolamide, Furosemide • Take several days before seeing the change

  23. Treatment: Blood • Keep midline for optimal drainage • HOB >30º • MAP highest when supine • ICP lowest when head elevated • 30º in small study gave best CPP

  24. Treatment: BloodTemp Control • Lowers CMRO2 • Decreases CBF • Neuroprotective • Less inflammation • Less cytotoxicity and thus less lipid peroxidation • Mild 32-34º • Lower can cause arrhythmias, suppressed immune system

  25. Treatment: BloodSedation & NMB • Adequate sedation and NMB reduce cerebral metabolic demands and therefore CBF and hence ICP

  26. Treatment: BloodHyperventilation • Decrease CO2 leads to CSF alkalosis causing vasoconstriction and decrease CBF and thus ICP • May lead to ischemia • Overtime the CSF pH normalizes and lose effect • Use mainly in acute deterioration and not as a mainstay therapy

  27. Treatment: BloodBarbiturate Coma • Lower cerebral O2 consumption • Decrease demand equals decrease CBF • Direct neuro-protective effect • Inhibition of free radical mediated lipid peroxidation

  28. Treatment: BrainOsmotic Agents • Mannitol • 1st described in 50’s • Historically thought secondary to movement of extra-vascular fluid into capillaries • Induces a rheologic effect on blood and blood flow by altering blood viscosity from changes in erythrocyte cell compliance • Transiently increases CBV and CBF • Cerebral oxygen improves and adenosine levels increase • Decrease adenosine then leads to vasoconstriction • May get rebound hypovolemia and hypotension

  29. Treatment: BrainOsmotic agents • Hypertonic Saline • First described in 1919 • Decrease in cortical water • Increase in MAP • Decrease ICP

  30. Treatment: Decompressive craniotomy • Trend toward improved outcomes

  31. Treatment: Steroids • Not recommended • CRASH study actually showed increased morbidity and mortality

More Related